Quantification of trabectedin in human plasma: Validation of a high-performance liquid chromatography–mass spectrometry method and its application in a clinical pharmacokinetic study-Reference-Cited by-同舟云学术

Quantification of trabectedin in human plasma: Validation of a high-performance liquid chromatography–mass spectrometry method and its application in a clinical pharmacokinetic study

Published:2014-07 Issue: Volume:95 Page:107-112
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Zangarini Monique,Ceriani Laura,Sala Federica,Marangon Elena,Bagnati Renzo,D’Incalci Maurizio,Grosso Federica,Zucchetti Massimo

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference10 articles.

1. A review of trabectedin (ET-743): a unique mechanism of action;D’Incalci;Mol. Cancer Ther.,2010

2. Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series;Grosso;Ann. Oncol.,2009

3. Analysis of Ecteinascidin 743, a new potent marine-derived anticancer drug, in human plasma by high-performance liquid chromatography in combination with solid-phase extraction;Rosing;J. Chromatogr. B,1998

4. Quantitative determination of Ecteinascidin 743 in human plasma by miniaturized high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry;Rosing;J. Mass Spectrom.,1998

5. Simple and sensitive liquid chromatographic quantitative analysis of the novel marine anticancer drug Yondelis (ET-743, trabectedin) in human plasma using column switching and tandem mass spectrometric detection;Stokvis;J. Mass Spectrom.,2004

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physicochemical stability of lurbinectedin reconstituted at 500 μg/mL and diluted at 15, 30, and 70 μg/mL in 0.9% sodium chloride and 5% dextrose;European Journal of Oncology Pharmacy;2021-07

2. Pharmacokinetics of Marine-Derived Drugs;Marine Drugs;2020-11-09

3. Pharmacokinetics, safety, and activity of trabectedin as first‐line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group;Cancer;2020-08-04

4. Novel method for fast trabectedin quantification using hydrophilic interaction liquid chromatography and tandem mass spectrometry for human pharmacokinetic studies;Journal of Pharmaceutical and Biomedical Analysis;2020-06

5. Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin;British Journal of Cancer;2019-08-14